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Identification of CD72 as a Lymphocyte Receptor
for the Class IV Semaphorin CD100: A Novel
Mechanism for Regulating B Cell Signaling
tion by functioning as chemorepellents during neuronal
development (Kolodkin et al., 1992, 1993; Luo et al.,
1993; Yu and Kolodkin, 1999). Although the functions of
semaphorins have been initially addressed with respect
to neuronal guidance, it is becoming clear that sema-
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immune system. Antibody crosslinking of CD100 hasStanford, California 94305
been shown to provide a proliferative signal to T cells
in the presence of submitogenic doses of anti-CD3 or
anti-CD2 antibodies (Herold et al., 1995), suggesting thatSummary
CD100 may be involved in T cell activation. Association
of tyrosine phosphatases with CD100 has also beenWe have identified the lymphocyte semaphorin CD100/
suggested (Herold et al., 1996; Billard et al., 2000). OnSema4D as a CD40-inducible molecule by subtractive
the other hand, CD100-expressing transfectants havecDNA cloning. CD100 stimulation significantly en-
been reported to promote aggregation and survival ofhanced the effects of CD40 on B cell responses. Ad-
B cells in vitro, suggesting that CD100, like other sema-ministration of soluble CD100 markedly accelerated
phorin proteins, can function as a ligand through a func-in vivo antigen-specific antibody responses. CD100
tional receptor on lymphocytes (Hall et al., 1996). Re-receptors with different binding affinities were de-
cently, plexin-B1, which is widely expressed withtected on renal tubular cells (Kd 5 z1 3 1029 M) and prominent levels in the fetal brain and kidney, has beenlymphocytes (Kd 5 z3 3 1027 M). Expression cloning reported to be a high-affinity receptor for CD100 (Tam-revealed that the CD100 receptor on lymphocytes is
agnone et al., 1999). However, it is unknown whether
CD72, a negative regulator of B cell responsiveness.
plexin-B1 is also a functional receptor for CD100 in the
CD72 thus represents a novel class of semaphorin
immune system.
receptors. CD100 stimulation induced tyrosine de- CD72 is a 45 kDa type II transmembrane protein that
phosphorylation of CD72 and dissociation of SHP-1 belongs to the C-type lectin family (Nakayama et al.,
from CD72. Our findings indicate that CD100 plays a 1989; Von Hoegen et al., 1990). CD72 is expressed
critical role in immune responses by the novel mecha- throughout B cell differentiation from the earliest B cell
nism of turning off negative signaling by CD72. progenitors to mature B cells but is downregulated upon
terminal differentiation into plasma cells (Gordon, 1994;
Introduction Tutt Landolfi and Parnes, 1997). In some mouse strains,
CD72 is also expressed on subpopulations of T cells
The semaphorin family consists of a large number of (Robinson et al., 1997). Engagement of CD72 can trans-
phylogenetically conserved proteins, carrying a long form a subset of small resting B cells into blast cells
(approximately 500 amino acid residues) stretch of con- and induce proliferation of activated B cells (Subbarao
served “Sema domain” in the amino terminus (Yu and and Mosier, 1984; Yakura et al., 1986). Anti-CD72 mono-
Kolodkin, 1999). Based on additional structural features, clonal antibodies (mAbs) have been shown to block
the family has been divided into eight classes (Sema- BCR-mediated cell death, promote B cell survival and
phorin Nomenclature Committee, 1999). Many members proliferation, increase MHC class II expression, and en-
of the semaphorin family are critically involved in axon hance production and release of CD23 in B cells (Gordon
steering, fasciculation, branching, and synapse forma- et al., 1991; Katira et al., 1992; Gordon, 1994; Nomura
et al., 1996; Tutt Landolfi and Parnes, 1997). Many of
the effects of anti-CD72 mAbs on resting B cells arek To whom correspondence should be addressed (e-mail: kikutani@
significantly enhanced by CD40 stimulation (Gordon etragtime.biken.osaka-u.ac.jp).
# These authors contributed equally to the work. al., 1991; Gordon, 1994; Tutt Landolfi and Parnes, 1997).
Immunity
622
Figure 1. Expression of CD100 Is Upregulated on Activated T and B Cells
(A) Analysis of purified mCD100-Fc and mCD100-Flag by SDS-PAGE. Two micrograms of purified mCD100-Fc or mCD100-Flag was separated
by gradient PAGE (4%–20%) in the presence of 0.1% SDS under reducing or nonreducing conditions and visualized by silver staining. Molecular
weight markers (kDa) (Rainbow markers, Amersham) are shown on the left.
(B) Anti-mCD100 mAb binds specifically to CD100-CHO cells. Stable transfectants of CHOneo and CD100-CHO were established as described
in Experimental Procedures. CHOneo or CD100-CHO were stained with biotinylated anti-mCD100 mAb (BMA-12, rat IgG1) (solid line) or
biotinylated isotype-matched controls (dotted line) plus FITC-conjugated streptavidin.
(C) Splenic T cells, small resting B cells, or WEHI-231 cells were stained with biotinylated anti-mCD100 mAb (BMA-12) (solid line) or biotinylated
isotype-matched controls (dotted line) plus FITC-conjugated streptavidin before and 1 or 2 days after stimulation with Con A (2 mg/ml) or
anti-CD40 mAb (HM40-3, 1 mg/ml) and then analyzed by flow cytometry.
In some situations, IL-4 and CD72 signals act in synergy Results
with one another (Yakura et al., 1986). In addition, it
has been shown that anti-CD72 mAbs induce tyrosine CD100 Expression Is Upregulated on B Cells
by Physiological Stimuliphosphorylation of phospholipase C-g and CD19 and
activate Lyn, Blk, and Btk kinases (Venkataraman et In a screen for the genes induced in CD40-stimulated
B cells, we isolated the cDNA encoding the mouse ho-al., 1998a, 1998b). These observations imply that CD72
transmits positive signals for B cell activation. On the molog of human CD100 (Furuyama et al., 1996; Hall et
al., 1996) (see Experimental Procedures). To investigateother hand, cumulative evidence also suggests a poten-
tial role of CD72 as a negative regulator of B cell re- the function and expression of CD100, we first prepared
soluble CD100 protein consisting of the full length ofsponses. The cytoplasmic domain of CD72 contains two
immunoreceptor tyrosine-based inhibitory motifs (ITIMs). the putative extracellular region of mouse CD100 fused
with either human IgG1 Fc (mCD100-Fc) or with Flag-Adachi et al. (1998) have shown that crosslinking of the
BCR enhances tyrosine phosphorylation of CD72 and peptide (mCD100-Flag). As shown in Figure 1A, a band
of approximately 150 kDa was observed for mCD100-association of CD72 with the protein tyrosine phospha-
tase SHP-1, suggesting that CD72 might negatively reg- Fc under reducing conditions, and dimer formation was
apparent under nonreducing conditions; however, ho-ulate B cell activation. Consistent with this finding, a
recent study from one of our labs has shown that B modimerization of mCD100-Flag was rather unstable,
although CD100 containing its transmembrane and cy-cells from CD72-deficient mice are hyperproliferative in
response to various stimuli and have a more rapid Ca21 toplasmic domains has been reported to form homodi-
mers (Furuyama et al., 1996; Hall et al., 1996). To analyzeresponse following BCR stimulation (Pan et al., 1999).
Furthermore, preligation of CD72 with anti-CD72 mAb the cell surface expression of mCD100 on various types
of cells, we generated several anti-mouse CD100 mono-blocks tyrosine phosphorylation of CD72 and associa-
tion of SHP-1 with CD72, resulting in inhibition of BCR- clonal antibodies (anti-mCD100 mAb) by immunizing
rats with mCD100-Fc and screening hybridomas withinduced growth arrest/apoptosis signals (Wu et al.,
1998). These findings suggest that binding of a putative mCD100-Flag. As shown in Figure 1B, anti-mCD100
mAb (BMA-12; rat IgG1) specifically bound to mCD100-natural ligand to CD72 may switch its signaling from
positive to negative or vice versa, thereby controlling expressing CHO cell transfectants (CD100-CHO) but not
to CHO cells transfected with the neomycin resistancethe magnitude of B cell responses.
Here, we identify CD72 as a functional lymphocyte plasmid alone (CHOneo). Flow cytometric analysis using
anti-mCD100 mAb confirmed that mCD100 was ex-receptor for CD100 and demonstrate that CD100 stimu-
lation turns off negative signaling effects of CD72 by pressed abundantly on T cells and weakly on B cells
(Figure 1C), as reported for human CD100 (Delaire et al.,inducing tyrosine dephosphorylation of CD72 and disso-
ciation of SHP-1 from CD72. 1998). CD100 expression was considerably upregulated
CD72 Is a Receptor for CD100
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Figure 2. The Effects of CD100 on B Cell Responses
(A) The proliferative effects of CD100 on small resting splenic B cells. Small resting B cells purified from C57BL/6 mice were stimulated with
or without anti-CD40 mAb (1 mg/ml), IL-4 (10 U/ml), and mCD100-Fc (20 mg/ml), as indicated, for 3 days. Cells were pulsed with 2 mCi of
[3H]thymidine for the last 16 hr of the culture period and then [3H]thymidine uptake was measured.
(B) In vitro IgG1 production induced by CD40 is enhanced by CD100 stimulation. Small resting B cells were stimulated with or without anti-
CD40 mAb (1 mg/ml) and IL-4 (10 U/ml) in the presence of paraformaldehyde fixed CHOneo or CD100-CHO cells for 7 days. Concentrations
of IgM and IgG1 in the culture supernatants were determined by ELISA.
(C) The effects of mCD100-Fc treatment on in vivo antigen-specific antibody responses. Purified human IgG1 myeloma protein (white bars)
or mCD100-Fc (black bars) was injected at 100 mg/day for 12 days after intraperitoneal immunization with 100 mg alum-precipitated NP-CGG.
Serum titers of anti-NP-specific IgG1 antibodies were assayed by ELISA using NP12-BSA. The concentrations of anti-NP IgG1 antibodies were
estimated by comparison to standard curves created from pooled sera of C57BL/6 mice 12 days after immunization. The concentrations of
anti-NP IgG1 present in a 1:1000 dilution of pooled immune sera of C57BL/6 mice was defined as one arbitrary unit (Uchida et al., 1999). The
values shown are the means 6 SD of ten mice per group. *p , 0.05, **p , 0.01, **p , 0.005. Each value was statistically analyzed by unpaired
t test.
by Con A stimulation of T cells and CD40 stimulation later. Collectively, the effects of CD100 stimulation on
in vitro and in vivo antibody responses indicate that theof splenic B cells and WEHI-231 cells (Figure 1C). As
expected from our cloning methodology of CD100 lymphocyte semaphorin CD100 plays a critical role in
humoral immune responses.cDNA, the upregulation of surface CD100 on B cells
correlated with increased CD100 mRNA (data not
shown). Two Types of Receptors for CD100 with Different
Binding Kinetics
Human plexin-B1 has been shown to be a high-affinityCD100 Stimulation Synergistically Enhances
CD40-Mediated B Cell Responses receptor for human CD100 (Tamagnone et al., 1999).
The expression of plexin-B1 is reported to be detected inWe expected that CD100 might function as a ligand
for a cell surface receptor, like other members of the a broad range of fetal and adult tissues, with prominent
levels in the fetal kidney and brain (Maestrini et al., 1996).semaphorin family. We therefore examined effects of
CD100 on in vitro B cell responses in which CD40 signal- The expression of CD100 has also been observed in
a broad range of tissues, including brain, kidney, anding has been shown to play a role. Stimulation of normal
splenic B cells with mCD100-Fc enhanced B cell prolifer- lymphocytes (Furuyama et al., 1996; Hall et al., 1996).
We examined the distribution of CD100 binding sitesative responses to anti-CD40 mAb plus IL-4 (Figure 2A).
Moreover, addition of CD100-expressing CHO cells sig- using various mouse tissue-derived cell lines. Through
binding analysis using soluble mCD100-Fc, we found atnificantly increased IgG1 but not IgM production of B
cells stimulated with anti-CD40 mAb and IL-4 (Figure least two types of receptors for CD100. As shown in
Figure 3A, mCD100-Fc bound to the Prox24 cell line2B). These results indicate that CD100 exerts synergistic
effects on CD40-induced B cell responses. (derived from mouse renal tubular cells) with high-affinity
binding kinetics (Kd 5 z1 3 1029 M, corresponding to theTo determine whether CD100 plays a role in antigen-
specific antibody production in vivo, mice were immu- affinity reported for the human CD100–human plexin-B1
interaction). In contrast, mCD100-Fc bound to WEHI-nized with a T-dependent antigen, 4-hydroxy-3-nitro-
phenylacetyl-chicken-g-globulin conjugates (NP-CGG), 231 cells with lower affinity binding kinetics (Kd 5 z3 3
1027 M). Mouse plexin-B1 has not been described pre-and then treated with soluble mCD100-Fc. As shown in
Figure 2C, mice treated with soluble mCD100-Fc exhib- viously. We isolated a mouse plexin-B1 cDNA fragment
from a Prox24 cDNA library by PCR cloning using degen-ited significantly enhanced NP-specific IgG1 antibody
levels even 6 days after immunization, which was almost erate oligonucleotide primers based on conserved se-
quences among members of the plexin family (data notcomparable to those seen in untreated mice 12 days
Immunity
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gated with streptavidin. Cells binding mCD100-Fc were
enriched by magnetic sorting. A discrete band corre-
sponding to a 1.4 kb insert appeared after the fourth
round of sorting, whereas no bands were apparent with
cells binding human immunoglobulin Fc fractions (Fig-
ure 5A). We sequenced the 1.4 kb cDNA inserts of these
clones and found that they were full-length cDNAs en-
coding mouse CD72. CD72 was originally defined as an
allotypic determinant on mouse B lymphocytes (Sato
and Boyse, 1976). The cDNA of CD72 we isolated here
was identical to the b allele (Robinson et al., 1992), which
is known to be expressed on a subset of T cells and to
be further inducible by T cell activation (Robinson et al.,
1997). This is in good agreement with our observation
that mCD100-Fc binds not only to B cells but also to
activated T cells. As shown in Figure 5B, biotinylated
mCD100-Fc specifically bound to CD72-expressing
CHO cell transfectants (CD72-CHO) but not to control
transfectants (CHOneo). Anti-CD72 mAb specifically
blocked the binding of mCD100-Fc to B cells (Figure
5C). Furthermore, mCD100-Fc did not bind to CD72-
deficient B cells (Figure 5D), nor did it enhance theirFigure 3. Two Types of Receptors for CD100 with Different Binding
proliferation or immunoglobulin production induced byKinetics
anti-CD40 plus IL-4 (Figure 5F). mCD100-Fc also failed(A) Scatchard analysis of 125I mCD100-Fc binding to Prox24 cells or
to bind Con A–activated T cells from CD72-deficientWEHI-231 cells. Prox24 cells or WEHI-231 cells were incubated in
the presence of Fc block as triplicate samples in the presence or mice (data not shown). The results demonstrate that
absence of excess mCD100-Fc for 2 hr. The cell pellet and superna- CD100 binds specifically to and exerts its function
tant were assessed for bound and free 125I cpm, respectively. CD40- through CD72.
Fc protein did not show specific binding under those experimental
conditions (data not shown). Values for Kd were obtained by Scatch-
Properties of CD100–CD72 Bindingard analysis as described (Hara and Miyajima, 1992).
(B) RT–PCR for expression of murine plexin-B1. Several cDNA frag- To investigate the properties of binding of CD100 to
ments of murine plexin-B1 were isolated by degenerate PCR cloning CD72, we prepared soluble recombinant CD72 protein
as described in Experimental Procedures. RNA was isolated from consisting of the full length of the extracellular region
mouse brain, Prox24 cells, and splenic T cells and B cells and then of CD72 and Flag-peptide (CD72-Flag). As shown in
treated with DNase I to exclude genomic DNA. For negative controls,
Figure 6A, SDS-PAGE of purified recombinant CD72-RT2 samples were applied to PCR amplifications.
Flag protein resulted in a band of approximately 32 kDa
under reducing conditions and 64 kDa, consistent with
dimer formation, under nonreducing conditions. Solubleshown). We examined the expression of plexin-B1 in
mouse lymphocytes by RT–PCR. Although plexin-B1 recombinant CD72-Flag protein was immobilized on a
BIAcore sensor chip surface via an anti-Flag mAb. Astranscripts were highly expressed in Prox24 cells and
brain, the expression of plexin-B1 could not be detected shown in Figure 6B, when anti-CD72 mAb was injected
over the chip, a typical profile of antibody binding wasin primary mature T and B cells (Figure 3B). The effects
of CD100 on B cell responses that we observed here observed. We measured the binding affinity between
CD100 and CD72 with the BIAcore system by injectingimply that lymphocytes express functional receptors for
CD100 that are distinct from plexin-B1. We thus stained increasing concentrations of mCD100-Fc over the sen-
sor surface containing immobilized CD72-Flag (Figurevarious cells with biotinylated mCD100-Fc to search for
CD100 receptors on lymphocytes. Splenic B cells as 6C). The mCD100-Fc samples were similarly injected
over sensor surfaces containing only immobilized anti-well as WEHI-231 B cells were specifically stained by
mCD100-Fc (Figures 4A and 4B). In addition, binding Flag mAb (without soluble CD72-Flag protein) to mea-
sure the background response. For each mCD100-Fcof biotinylated mCD100-Fc was detected on activated
splenic T cells and T cell hybridomas but not on resting concentration, the binding response at equilibrium was
calculated by subtracting the response seen in the con-splenic T cells or thymocytes (Figures 4C–4F).
trol flow cell from the response seen in the CD72-immo-
bilized cells, resulting in a Kd value of z3 3 1027 M byExpression Cloning Reveals that CD72
Is a Receptor for CD100 equilibrium binding analysis. Neither CD5-Fc nor CD40-
Fc could bind to recombinant CD72 protein immobilizedFor expression cloning of the CD100 receptor on lym-
phocytes, we constructed a cDNA library from Con A– on a BIAcore sensor chip (data not shown). Scatchard
analysis using CD72-CHO cells and radioiodinatedstimulated T cell hybridoma 2B4 cells, since these abun-
dantly express CD100 binding sites (Figure 4F). Plasmid mCD100-Fc revealed that CD100 bound to CD72-CHO
cells with a Kd of z3 3 1027 M (data not shown), whichDNA from the entire library was introduced into COS7
cells. The transfected COS7 cells were allowed to bind is comparable to the binding affinity of mCD100-Fc for
WEHI-231 cells (Figure 3). Since CD72 belongs to thebiotinylated mCD100-Fc or biotinylated human immuno-
globulin Fc fractions followed by magnetic beads conju- C-type lectin family, there is a possibility that CD72 may
CD72 Is a Receptor for CD100
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Figure 4. Flow Cytometric Analysis of CD100
Receptor
WEHI-231 cells (A), splenic B cells (B), thymo-
cytes (C), splenic T cells (D), Con A (2 mg/ml)
stimulated T cells (E), or T cell hybridoma 2B4
cells (F) were incubated with biotinylated
mCD100-Fc (60 nM) in the presence of Fc
block on ice for 1 hr, stained with FITC-conju-
gated streptavidin on ice for 20 min, and
analyzed by flow cytometry (solid line). The
profiles of cells stained with biotinylated
mCD40-Fc (van Essen et al., 1995) (A and B)
or human immunoglobulin Fc fractions (C–F)
plus FITC-conjugated streptavidin are also
shown (dotted line).
bind to carbohydrate moieties of CD100. While not to- been shown to form receptor complexes with neuropi-
lins (Takahashi et al., 1999; Tamagnone et al., 1999).tally excluding this possibility, treatment with glycosi-
Human plexin-B1 has been recently cloned as a high-dases did not affect the binding of mCD100-Fc to B
affinity binding receptor for CD100 (Tamagnone et al.,cells or CD72-CHO cells (Figure 6D).
1999). We also detected high-affinity binding sites forCD72 has been shown to have ITIMs and to associate
CD100 on mouse renal tubular cells that express plexin-with SHP-1 via phosphorylated tyrosine residues of
B1. Plexin-B1 transcripts were detected in these mouseCD72 (Adachi et al., 1998; Wu et al., 1998). In addition,
renal tubular cells but not in mouse primary lympho-preligation of CD72 by anti-CD72 mAbs was shown to
cytes. Our study therefore shows that CD72 is a novelblock tyrosine phosphorylation of CD72 in anti-m stimu-
type of semaphorin receptor distinct from neuropilinslated B cells (Wu et al., 1998). We thus tested whether
and plexins. Furthermore, B cell responses were se-CD100 stimulation could reproduce the effects of anti-
verely impaired in CD100-deficient mice, but develop-CD72 mAb on CD72-mediated signals. When WEHI-231
mental defects were not apparent in other tissues (ShiB cells were stimulated with anti-m, CD72 was tyrosine
et al., 2000 [this issue of Immunity]). It thus appears thatphosphorylated and associated with SHP-1, as pre-
CD100–CD72 interactions play a nonredundant role inviously reported (Wu et al., 1998). Pretreatment of B
the immune system and that if plexin-B1 has essentialcells with mCD100-Fc but not CD40-Fc (control fusion
roles, it may have other ligands. However, we cannotprotein) could abrogate both tyrosine phosphorylation
completely exclude the possibility that, in addition toof CD72 and association of SHP-1 with CD72 (Figure
CD72, a neuropilin or plexin molecule other than plexin-7A). Furthermore, when transiently expressed in COS7
B1 may be involved in mediating CD100 signals in thecells, CD72 was constitutively tyrosine phosphorylated
immune system.and associated with SHP-1. CD100 stimulation induced
CD72 has been a “wandering B cell antigen” until now.tyrosine dephosphorylation of CD72 and dissociation of
Although at one time the possibility was raised thatSHP-1 from CD72 in these cells (Figure 7B). These re-
CD72 might serve as a receptor for IL-4 (Yakura et al.,sults suggest that CD100 binding may turn off negative
1986), this is now known not to be the case. CD72 hassignaling through CD72 by dissociating SHP-1.
been suggested to be a ligand for CD5 because CD5
protein purified from detergent-solubilized T cells was
Discussion shown to bind to CD72-expressing cells (Van de Velde
et al., 1991). However, other reports have shown that
CD72 Is a Functional Receptor for CD100 recombinant CD5-Fc fusion protein consisting of the
in the Immune System extracelluar domain of CD5 and human IgG bound not to
We have demonstrated expression of two types of CD72 but to a 35–37 kDa protein and/or two polypeptide
CD100 receptors in different cell types and have identi- chains of 77–80 and 37–40 kDa on activated B cells
fied CD72 as a functional lymphocyte receptor for (Biancone et al., 1996; Bikah et al., 1998). Furthermore,
CD100. Neuropilins and plexins have been shown to be we could not find specific binding between recombinant
receptors for several members of the semaphorin family CD72 and CD5-Fc using the BIAcore instrument (data
(He and Tessier Lavigne, 1997; Kolodkin et al., 1997; not shown). The present study has clearly shown that
Comeau et al., 1998; Winberg et al., 1998; Takahashi et CD100 is a bona fide ligand for CD72. Some of the
al., 1999; Tamagnone et al., 1999). Although neuropilins previously reported effects of anti-CD72 mAbs on B
have very short cytoplasmic domains that contain no cells (Gordon, 1994; Tutt Landolfi and Parnes, 1997) are
obvious signaling motifs, they are indispensable for re- similar to those of CD100 transfectants and mCD100-
pulsive semaphorin guidance (Nakamura et al., 1998), Fc revealed by us and others (Hall et al., 1996). Further-
suggesting that they serve a critical role in assembling more, the binding affinity between CD100 and CD72
a receptor complex that includes a transmembrane sig- (Kd 5 z3 3 1027 M) is comparable to or higher than those
naling component. Plexins, which are more recently of other adhesion or costimulatory molecules, such as
CD2-CD58 (Kd 5 z1 3 1026 M) and CD80-CD28 (Kd 5identified receptors for the semaphorin family, have
Immunity
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Figure 5. CD72 Is a Receptor for CD100
(A) Magnetic sorting enriched discrete 1.4 kb cDNA inserts (upper). No apparent bands were enriched after control sorting using biotinylated
human immunoglobulin Fc fractions plus magnetic beads conjugated with streptavidin (lower). The band of 3 kb corresponds to the pME18S
vector. Plasmid DNAs before 0 and after 1–4 magnetic sorting were digested with NotI and EcoRI to identify inserts and electrophoresed on
1% agarose gels.
(B) mCD100-Fc binds to CD72-CHO. (Upper) CHOneo or CD72-CHO cells were established as described in Experimental Procedures and
stained with biotinylated anti-CD72 (IOT72-2) plus FITC-conjugated streptavidin (solid line) or FITC-conjugated streptavidin alone (dotted line).
(Lower) mCD100-Fc binds to CD72-CHO cells. CHOneo or CD72-CHO cells were stained with biotinylated mCD100-Fc (solid line) or biotinylated
mCD40-Fc plus FITC-conjugated streptavidin (dotted line).
(C) Anti-CD72 mAb specifically blocks the binding of mCD100-Fc to CD72 on B cells. B cells from DBA/2 mice were preincubated with 5 mg
of anti-CD72 mAb (mouse anti-CD72; 9-6.1, Yakura et al., 1986) (thin line) or mouse IgG2b as an isotype control (thick line), stained with
biotinylated mCD100-Fc plus FITC-conjugated streptavidin or FITC-conjugated streptavidin alone (dotted line), and analyzed by flow cytometry.
(D) mCD100-Fc does not bind to CD72-deficient B cells. Spleen cells were prepared from wild-type (left) or CD72-deficient mice (Pan et al.,
1999) (right) and then stained with phycoerythrin-conjugated anti-B220 and biotinylated mCD100-Fc (solid line) or mCD40-Fc (dotted line)
plus FITC-conjugated streptavidin. B220-positive cells were gated and analyzed for mCD100-Fc binding by flow cytometry.
(E) CD72-deficient B cells do not respond to CD100 stimulation. Wild-type (open circles or bars) or CD72-deficient (filled circles or bars) small
resting B cells were prepared and stimulated with mCD100-Fc in the presence of anti-CD40 mAb (0.5 mg/ml) and IL-4 (10 U/ml) for 3 days
for proliferation (E) or 7 days for immunoglobulin production (F).
z1 3 1026z1027 M) or -CTLA-4 (Kd 5 z1 3 1026z1027 perproliferative, confirming this notion (Pan et al., 1999).
Therefore, CD100 stimulation may enhance B cell re-M) (van der Merwe et al., 1997), all of which play signifi-
cant roles in immune responses. sponses by turning off the negative signaling effects of
CD72. In fact, our accompanying report shows that the
immunological phenotype of CD100-deficient mice isCD100 Turns off Negative Signals of CD72
We have shown here that CD100 stimulation induces almost the mirror image of that of CD72-deficient mice
(Shi et al., 2000). The homeostasis of the immune systemtyrosine dephosphorylation of CD72, leading to SHP-1
dissociation from CD72 (Figure 7). These effects are is delicately controlled by both positive and negative
regulators. Like CD72, many negative regulators, includ-consistent with previous studies showing that anti-CD72
mAb treatment blocks tyrosine phosphorylation of CD72 ing killer inhibitory receptors, some Fc receptors, and
CD22, contain ITIM motifs and are associated with vari-and recruitment of SHP-1 to CD72 in anti-m stimulated
B cells (Wu et al., 1998). CD72 has been postulated to ous tyrosine phosphatases (Daeron et al., 1995; Tedder
et al., 1997; Lanier, 1998; Falco et al., 1999). In mostplay a role in B cell development and B cell responses
as a negative regulator. CD72-deficient B cells are hy- cases, ligand binding to these receptors transmits nega-
CD72 Is a Receptor for CD100
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Figure 6. Properties of Binding between CD100 and CD72
(A) SDS-PAGE analysis of purified recombinant soluble CD72. Three hundred nanograms of purified recombinant soluble CD72 protein was
separated by SDS-PAGE under reducing or nonreducing conditions and visualized by silver staining. Molecular weight markers (kDa) are
shown on the right.
(B) Anti-CD72 mAb specifically recognizes recombinant soluble CD72-Flag protein. Anti-CD72 mAb (K10.6; mouse IgG2b, 10 mg/ml) was
injected through the flow cell with recombinant CD72-Flag immobilized via anti-Flag mAb on a sensor chip. The recombinant CD72 protein
was specifically recognized by anti-CD72 mAb. As a negative control, anti-CD40 mAb or mouse IgG2b (10 mg/ml) was injected using the same
experimental conditions.
(C) Measuring the affinity of mCD100-Fc binding to recombinant CD72-Flag protein by surface plasmon resonance. A range of mCD100-Fc
concentrations (54, 27, 18, 14, and 9 nM) was injected sequentially through the flow cell with recombinant CD72-Flag immobilized via anti-
Flag mAb on the sensor chip (upper). As a control, the mCD100-Fc samples were injected through a flow cell with sensor chips coated with
anti-Flag mAb alone without recombinant CD72-Flag (lower). The binding response at equilibrium was calculated by subtracting the response
in the control from the response with the CD72-immobilized chip. The Kd was estimated by BIAcore evaluation software.
(D) Deglycosylation of mCD100-Fc does not block the binding of mCD100-Fc to CD72. After 24 hr treatment with N-glycosidase F or
O-glycosidase, treated and nontreated mCD100-Fc were analyzed by SDS-PAGE. B cells or CD72-CHO cells were stained with glycosidase-
treated or nontreated biotinylated mCD100-Fc proteins plus FITC-conjugated streptavidin (solid line). As a negative control, cells were stained
with biotinylated human immunoglobulin Fc plus FITC-conjugated streptavidin (dotted line).
tive signals to suppress lymphocyte functions. Our find- findings will provide not only novel insights into the regu-
lation of humoral immune responses but also clues forings may be the first example of ligand binding to a
negative regulator leading to positive stimulation of lym- the development of vaccines to potentiate antigen-spe-
cific antibody production.phocytes. However, it is still unknown whether CD72
alone is responsible for CD100 signals or whether an-
other unknown protein might associate with CD72 and
Experimental Procedures
also function as a signaling molecule. Thus, further stud-
ies to search for CD72-associated proteins other than PCR-Based cDNA Subtraction
Aliquots of 1 3 108 WEHI-231 cells were stimulated with an anti-SHP-1 may be necessary.
CD40 mAb, HM40-3 (PharMingen), for 8 hr. Total RNA from CD40-In conclusion, we demonstrate that the lymphocyte
stimulated or unstimulated WEHI-231 cells was isolated using gua-semaphorin CD100 binds to CD72, establishing the first
nidinium isothiocyanate phenolic acid, and mRNA was purified byendogenously expressed semaphorin receptor binding
oligo(dT)-coupled magnetic beads (PolyA Tract mRNA Isolation Sys-
pair in the immune system. Moreover, the CD100–CD72 tems, Promega). cDNA synthesis and subtraction were performed
interaction results in strong B cell costimulation by the using a PCR-Select cDNA subtraction kit (Clontech). The resulting
cDNA fragments that were induced by CD40 stimulation were di-unique mechanism of turning off negative signaling. Our
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from culture supernatants by protein A–Sepharose (Pharmacia), and
mCD100-Flag protein was affinity purified by anti-Flag mAb (M2)
conjugated with agarose (Sigma).
Transfectants
Stable mCD100- or CD72-expressing CHO cell transfectants were
generated by introducing full-length Flag-tagged mCD100 or CD72
cDNAs in the pMC1neo vector using Lipofectamine Plus (Life Tech-
nologies). Transfectants expressing CD100 (CD100-CHO) or CD72
(CD72-CHO) were selected by anti-FLAG (M2, Sigma) or anti-CD72
(IOT72-2, Immunotech, Marseille, France) mAb and cloned. As a
control transfectant, CHOneo was generated by transfection of CHO
cells with the pMC1neo vector alone.
Antibodies
Anti-mCD100 mAb (BMA-12) was established as follows. Rats were
immunized three times and boosted once with 100 mg of mCD100-
Fc fusion protein. Rat splenocytes were fused with P3U1 cells, and
7 days later, hybridomas were tested for the production of specific
antibodies by ELISA using mCD100-Fc and mCD100-Flag. Positive
results were confirmed by flow cytometry using CD100-CHO. Anti-
CD72 (H-96), anti-phosphotyrosine (PY99), and anti-SHP-1 (C19)
antibodies were purchased from Santa Cruz Biotechnology, and
F(ab9)2 fragments of goat anti-mouse IgM (m chain) antibodies were
from ICN Pharmaceuticals. Anti-CD72 mAb (K10.6) that recognizes
the extracellular region of CD72 was purchased from PharMingen.
Flow Cytometric Analysis for Expression of CD100
and Its Receptor
Anti-mCD100 mAb (BMA-12; rat IgG1), mCD100-Fc, mCD40-Fc
(kindly provided by Dr. D. Gray, Edinburgh, U.K.) (van Essen et al.,
1995), or human immunoglobulin Fc fractions (Chemicon Interna-
tional, Inc.) were biotinylated using a biotinylation kit (Boehringer
Figure 7. CD100 Induces Tyrosine Dephosphorylation of CD72 and Mannheim). For flow cytometric analysis for CD100 receptors, ali-
Dissociation of SHP-1 quots of 106 cells were incubated with biotinylated mCD100-Fc (60
nM), mCD40-Fc (60 nM), or human immunoglobulin Fc on ice for 1(A) WEHI-231 cells (1 3 107 cells/lane) were pretreated with or with-
hr containing 5 mg/ml of Fc block (PharMingen). After washing without mCD100-Fc (60 mg/ml) or CD40-Fc (40 mg/ml) (control fusion
staining buffer, the cells were stained for 20 min with FITC-conju-protein) for 15 min on ice and then stimulated with F(ab9)2 anti-m (10
gated streptavidin (PharMingen). Cells were then washed and ana-mg/ml) for 1 min at 378C.
lyzed by a flow cytometer.(B) COS7 cells that were transfected with CD72 cDNA by lipofection
2 days before were stimulated with mCD100-Fc for 1 min. Cell ly-
sates (1% NP40) were immunoprecipitated with anti-CD72 (H-96) or Assays for Proliferation and Immunoglobulin Production
anti-SHP-1 (C19) and blotted with anti-phosphotyrosine Abs (PY99), Nonadherent splenic B cells from C57BL/6 mice (6–8 weeks) were
anti-SHP-1 (C19), or anti-CD72 (H-96) mAbs. isolated with a combination of anti-Thy1.2 (F7D5, Seroteck Ltd, U.K.)
and rabbit complement (Wako, Japan). The remaining B cells were
further fractionated through a Percoll gradient of 50%, 60%, 66%,
and 70%, and cells at the interface between 66% and 70% wererectly ligated into a T/A vector (Novagen). The inserts were se-
collected. The resulting small resting splenic B cells (1 3 105 cells/quenced and analyzed by comparisons against GenBank and dbest
well) were stimulated with or without anti-CD40 mAb (1 mg/ml) anddatabases.
IL-4 (10 U/ml) in the presence of mCD100-Fc (20 mg/ml) or with
paraformaldehyde fixed CHOneo or CD100-CHO cells (2 3 104 cells/Production of Soluble mCD100 Proteins
well) in flat-bottomed 96-well microtiter plates for 3 days for prolifer-A truncated form of mCD100 cDNA was prepared from a full-length
ation or 7 days for immunoglobulin production. Cells were pulsedmCD100 cDNA derived from CD40-stimulated WEHI-231 cells by
with 2 mCi [3H]thymidine for the last 16 hr. Immunoglobulin produc-PCR using a pair of oligonucleotide primers containing a sense
tion was estimated by ELISA (Kawabe et al., 1994).sequence including a SalI site (59-GCTGTCGACTGTGTGCCCGTTG
CTGAAGGCCT-39) and an antisense sequence including a BamHI
site (59-GACGGATCCTACTTACTTTGCTTTGCTTGCTTGAGATA Isolation of cDNA Fragments of Murine Plexin-B1
Based on the sequences conserved among human plexin-B1, A1,CACCGTCTTCTCTGA-39) for mCD100-Fc, or an antisense sequence
including a NotI site and Flag (DYKDDDDK) sequence (59-AGGCGG A2, and A3 and mouse plexin-A1, A2, and A3, degenerate
59(GTGAAA/GGTA/G/CCTA/GGAC/TTGTGAC/TAC) and 39 (AACACCGCTTACTTGAGATACACCGTCTTCTCTGA-39) for mCD100-Flag.
The resulting SalI–BamHI fragments or SalI–NotI fragments were GA/GTCA/GTCC/GACA/GAAT/CTTT/CTG) oligonucleotides were
used for PCR amplification, using cDNA derived from the mouseused to replace the SalI–BamHI DNA fragment or SalI–NotI DNA
fragments of the pEFBos human IgG1 Fc cassette (Suda and Nagata, renal tubular cell line, Prox24 (kindly provided by Drs. Y. Hirata and
T. Sugaya, Tanabe, Japan) (948 for 1 min; 508 for 1 min; 728 for 11994) to generate mCD100-Fc or mCD100-Flag proteins. To produce
these soluble mCD100 proteins, stable P3U1 plasmacytoma trans- min; 30 cycles). Amplification products were cloned into a T/A vector
(Novagen) and sequenced. One 460 base pair amplification productformants carrying the expression plasmid were established by elec-
troporation. Briefly, aliquots of 107 cells were transfected with 50 encoded the mouse homolog of plexin-B1, exhibiting z83% identi-
cal nucleotides and z95% identical amino acid residues comparedmg of the plasmid DNA digested with HindIII for pEFBos-mCD100-
Fc or mCD100-Flag or 5 mg of pMC1neo vector digested with BamHI to human plexin-B1. Based on the sequence of mouse plexin-B1,
RT–PCR, using 59 (TGTGACACCATCTCCCAGGC) and 39 (AGCCTTby electroporation. After selection in RPMI medium containing 10%
FCS and 0.3 mg/ml of G418 for 10 days, individual G418-resistant TGGCTTGGCTAACG) oligonucleotide primers, was performed (948C
for 30 s; 628C for 30 s; 728C for 30 s; 35 cycles).colonies were isolated and cloned. mCD100-Fc protein was purified
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Construction of the cDNA Library and Expression Cloning (H-96) or anti-SHP-1 (C19) for 3 hr at 48C. After washing with the
lysis buffer four times, immunoprecipitates were subjected to SDS-2B4 cells were grown to 1 3 106 cells/ml in RPMI containing 10%
FCS and then stimulated with Con A (2 mg/ml) for 18 hr. Total cellular PAGE and then electrophoretic transfer to nitrocellulose mem-
branes. Membranes were immunoblotted with anti-CD72 (H-96),RNA was isolated by guanidinium isothiocyanate gradient centrifu-
gation, and mRNA was selected using oligo(dT)-coupled magnetic anti-SHP-1 (C19), or anti-phosphotyrosine Abs (PY99), and the blots
were developed by enhanced chemiluminescence (ECL) reagent fol-beads (PolyA Tract mRNA Isolation System, Promega). Double-
stranded cDNA primed with oligo(dT) was synthesized using a Su- lowing the manufacturer’s protocol (Amersham Pharmacia Biotech).
perScriptII cDNA synthesis kit (Life Technologies). A BstXI adaptor
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